After moving sharply lower on tariff fears to start the week, stocks rallied as most economic indicators point to an economy that’s growing strongly. An in-line reading on the November PCE inflation ...

A major technological advance in DNA writing enables researchers to construct and create in the language of biology ...

Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...

Trade blocs used to be built on ports, pipelines, and tariff schedules. In January 2026, the real borders are quieter: royalty rates, injunction risk, export classifications, cloud access rules, ...

In this week’s edition of InnovationRx, we look at why Yann LeCun’s AI startup is focused on healthcare, Epic’s new ...

We came across a bearish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bears’ thesis on ARE. Alexandria ...

Milwaukee Area Technical College has opened a biotechnology lab at its downtown Milwaukee campus, where students ...

Moderna’s Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. | Moderna’s Chief Medical Officer Jacqueline Miller, M.D., is stepping down after ...

Moderna has out-licensed a rare disease drug candidate to Recordati, accepting $50 million upfront for an asset that could ...

From STAT’s Andrew Joseph: GSK said this morning that it would buy RAPT Therapeutics in a deal worth $2.2 billion, picking up ...

Moderna (MRNA) stock surged 28.9% this week—see the 10 ETFs with the biggest MRNA weightings and which health care/biotech funds may benefit.

Syracuse, NY — A couple years ago, Syracuse’s biotech accelerator was full and looking to expand. But then its biggest tenant, Quadrant Biosciences, an autism screening company, went belly up. Now, ...